ImmunityBio Announces NCCN® Clinical Practice Guidelines in Oncology Have Been Updated to Include ANKTIVA® Plus BCG for Patients With BCG-Unresponsive NMIB…

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the National Comprehensive ...
Healio

Top 10 practice takeaways from 2026 dyslipidemia guideline

Dyslipidemia is highly prevalent and the primary direct driver of atherosclerotic CVD. In the more than 7 years since the ...
CURE

NCCN Guidelines Expand Options for Certain Bladder Cancer Patients

NCCN now includes Anktiva plus BCG for BCG-unresponsive papillary-only NMIBC, acknowledging an unmet need in patients without ...

NCCN Guideline Expansion Puts ANKTIVA And ImmunityBio Growth In Focus

NCCN has added ImmunityBio's ANKTIVA to its Clinical Practice Guidelines for BCG-unresponsive non muscle invasive bladder cancer with papillary only disease. This update extends recognized use of ...
Healio

‘Not all pituitary incidentalomas are the same’: New guidance refines management

Rising detection of pituitary incidentalomas has prompted a more individualized approach to surveillance and management.Incidentalomas are being found with greater frequency than in the past, ...
News-Medical.Net

Updated guideline emphasizes earlier treatment for high cholesterol

The American College of Cardiology (ACC), the American Heart Association and nine other leading medical associations, today ...
BMJ

Evidence-based clinical practice update: practice guidelines for anterior cruciate ligament rehabilitation based on a systematic review and multidisciplinary consensus

Aim The Royal Dutch Society for Physical Therapy (KNGF) instructed a multidisciplinary group of Dutch anterior cruciate ligament (ACL) experts to develop an evidence statement for rehabilitation after ...
ascopubs.org

Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline

Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update A multidisciplinary panel of ...